UCB (EBR:UCB) UCB Media Room: UCB successfully completes institutional Eurobond issue

Transparency directive : regulatory news

13/03/2024 18:30

https://u7061146.ct.sendgrid.net/ls/click?upn=3Du001.gqh-2BaxUzlo7XKIuSly0r= CyBv9bezcPT-2BuItTLKIHepbxTbo-2FYbVFPSBekB-2Bmk9X7Kl8shoTE6BsSbYYjHYcOVCrOC= rjYrJUHPDVbu1NKaBE-3DJKJb_2dCLUNbuBjhX746-2FvM63L9Hyn3KnTFGM-2BPPGCjZgmJl-2= FKl1Z2nt-2BIfez2IJ0TSaz3mplcEW6ZopJ4gUd4Ia3MTdQeFO93DwfIxs8cV3s33SbkEZvEGLN= n-2B6FohpNoV33GtN0NR9PvLYqDMQ144S-2FWKO8XVzhe0Rd-2BArGzkTxzzu-2BHDSphZDHOOn= ACj3TmpW-2FLow8mhHrczBp3vNkbNEuHBubSYppDAmiVbBjHgLHTwnu3M2bI9tctWGDTzfQGUvG= yhvwdY4XSWjbMi6dJT8YR-2B9Y0TQ71um04B99TWhcc1HP2zDk72PfQnilada1OGAxUtqSlD4CH= WO5XttdaceY3Wgp3-2FCLqnbDKtWuhXNFEt0-3D ** UCB successfully completes institutional Eurobond issue ------------------------------------------------------------ Brussels (Belgium), 13 March, 2024 =E2=80=93 18:30 (CET)=C2=A0 UCB SA/NV (=E2=80=9CUCB=E2=80=9D) announces today that it has successfully = completed the placement of EUR 500 million senior unsecured bonds with a co= upon of 4.25% and a tenor of 6 years. The bonds will be issued under its EU= R 5 billion EMTN Programme on 20 March 2024. Consistent with UCB=E2=80=99s prudent financial strategy, the net proceeds = of the bonds will be used for its general corporate purposes, including the= refinancing of the term loan debt incurred in April 2020 in connection wit= h the acquisition of Ra Pharmaceuticals, Inc., ahead of its April 2025 matu= rity date. Sandrine Dufour, Chief Financial Officer, UCB, commented, =E2=80=9CWe are v= ery pleased with the confidence investors have shown in us through their po= sitive response to this bond issuance. Following UCB=E2=80=99s successful i= ssuance of a Belgian retail bond in 2023, this transaction now also underli= nes UCB=E2=80=99s access to the institutional debt capital markets and furt= her extends our debt maturity profile.=E2=80=9D The bonds were placed with qualified institutional investors. The transacti= on was conducted by BofA Securities, BNP Paribas and Santander acting as gl= obal coordinators and active joint lead managers, IMI - Intesa Sanpaolo and= Wells Fargo Securities acting as active joint lead managers and Cr=C3=A9di= t Agricole CIB, ICBC and SMBC acting as co-lead managers for the issue. The bonds are expected to be listed and admitted to trading on the regulate= d market of Euronext Brussels. For further information, contact UCB:=C2=A0 Investor Relations Antje Witte, Investor Relations T +32 2 559 9414, antje.witte@ucb.com Julie Bayet, Investor Relations T +32 2 559 9580, julien.bayet@ucb.com Laurent Schots, Media Relations T +32 2 559 9264, laurent.schots@ucb.com=C2=A0 About UCB=C2=A0 UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With approximately 9,000 peopl= e in approximately 40 countries, the company generated revenue of =E2=82=AC= 5.3 billion in 2023. UCB is listed on Euronext Brussels (symbol: UCB). Foll= ow us on Twitter: @UCB_news. Disclaimer THIS COMMUNICATION IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY IN OR IN= TO THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTIO= N WOULD BE PROHIBITED BY APPLICABLE LAW.=C2=A0 THE ISSUE, EXERCISE AND SALE OF BONDS IN THE OFFERING ARE SUBJECT TO SPECIF= IC LEGAL OR REGULATORY RESTRICTIONS IN CERTAIN JURISDICTIONS. THE INFORMATI= ON CONTAINED HEREIN SHALL NOT CONSTITUTE OR FORM PART OF AN OFFER TO SELL O= R THE SOLICITATION OF AN OFFER TO BUY, NOR SHALL THERE BE ANY SALE OF THE B= ONDS REFERRED TO HEREIN, IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITAT= ION OR SALE WOULD BE UNLAWFUL. UCB ASSUMES NO RESPONSIBILITY IN THE EVENT T= HERE IS A VIOLATION BY ANY PERSON OF SUCH RESTRICTIONS.=C2=A0 THIS COMMUNICATION DOES NOT CONTITUTE AN OFFER TO SELL, OR A SOLLICITATION = OF OFFERS TO PURCHASE OR SUSCRIBE FOR, BONDS IN THE UNITED STATES OR ANY OT= HER JURISDICTION. THE BONDS MAY NOT BE OFFERED, EXERCISED OR SOLD IN THE UN= ITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS, ABSENT R= EGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER THE US SECURITIES ACT O= F 1933, AS AMENDED (THE "SECURITIES ACT"). UCB HAS NOT REGISTERED AND DOES = NOT INTEND TO REGISTER ANY PORTION OF THE OFFERING UNDER THE SECURITIES ACT= OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES, OR OTHER RELEVAN= T JURISDICTIONS WITHIN THE UNITED STATES, OR TO CONDUCT A PUBLIC OFFERING O= F ANY SECURITIES IN THE UNITED STATES.=C2=A0 This COMMUNICATION MAY ONLY BE COMMUNICATED, OR CAUSED TO BE COMMUNICATED, = TO persons in the United Kingdom in circumstances where the provisions of S= ection 21 of the Financial Services and Markets Act 2000, AS AMENDED (the = =E2=80=9CFSMA 2000=E2=80=9D) do not apply to UCB and is directed solely at = persons in the United Kingdom who (i) have professional experience in matte= rs relating to investments, such persons falling within the definition of = =E2=80=9Cinvestment professionals=E2=80=9D in Article 19(5) OF THE Financia= l Services and Markets Act (Financial Promotion) Order 2005, as amended (th= e =E2=80=9COrder=E2=80=9D) or (ii) are persons falling within Article 49(2)= (a) to (d) of the Order or others to whom it may lawfully be communicated (= all such persons together being referred to as =E2=80=9Crelevant persons=E2= =80=9D). Any investment activity to which this communication may relate is = only available to, and any invitation, offer or agreement to engage in such= investment activity will be engaged in only with, relevant persons. Any pe= rson who is not a relevant person should not act or rely on this presentati= on or any of its content.=C2=A0 THE BONDS REFERRED TO HEREIN ARE NOT INTENDED TO BE OFFERED, SOLD OR OTHERW= ISE MADE AVAILABLE TO, AND SHOULD NOT BE OFFERED, SOLD OR OTHERWISE MADE AV= AILABLE TO, ANY RETAIL INVESTOR IN THE EUROPEAN ECONOMIC AREA. FOR THESE PU= RPOSES, A RETAIL INVESTOR MEANS A PERSON WHO IS ONE (OR MORE) OF: (I) A RET= AIL CLIENT AS DEFINED IN POINT (11) OF ARTICLE 4(1) OF DIRECTIVE 2014/65/EU= , AS AMENDED (=E2=80=9CMIFID II=E2=80=9D) OR (II) A CUSTOMER WITHIN THE MEA= NING OF DIRECTIVE 2016/97/EU, AS AMENDED (THE =E2=80=9CINSURANCE DISTRIBUTI= ON DIRECTIVE=E2=80=9D), WHERE THAT CUSTOMER WOULD NOT QUALIFY AS A PROFESSI= ONAL CLIENT AS DEFINED IN POINT (10) OF ARTICLE 4(1) OF MIFID II. THE BONDS REFERRED TO HEREIN ARE NOT INTENDED TO BE OFFERED, SOLD OR OTHERW= ISE MADE AVAILABLE TO, AND SHOULD NOT BE OFFERED, SOLD OR OTHERWISE MADE AV= AILABLE TO, ANY RETAIL INVESTOR IN THE UNITED KINGDOM FOR THESE PURPOSES, A= RETAIL INVESTOR MEANS A PERSON WHO IS ONE (OR MORE) OF: (I) A RETAIL CLIEN= T AS DEFINED IN POINT (8) OF ARTICLE 2 OF REGULATION (EU) NO 2017/565 AS IT= FORMS PART OF DOMESTIC LAW BY VIRTUE OF THE European Union (Withdrawal) Ac= t 2018 (=E2=80=9CEUWA=E2=80=9D) OR (II) A CUSTOMER WITHIN THE MEANING OF TH= E PROVISIONS OF THE FSMA 2000 AND ANY RULES OR REGULATIONS MADE UNDER THE F= SMA 2000 TO IMPLEMENT THE INSURANCE DISTRIBUTION DIRECTIVE, WHERE THAT CUST= OMER WOULD NOT QUALIFY AS A PROFESSIONAL CLIENT AS DEFINED IN POINT (8) OF = ARTICLE 2(1) OF REGULATION (EU) NO 600/2014 AS IT FORMS PART OF DOMESTIC LA= W BY VIRTUE OF THE EUWA. CONSEQUENTLY, UCB HAS NOT PREPARED A KEY INFORMATION DOCUMENT FOR OFFERING = OR SELLING THE BONDS OR OTHERWISE MAKING THEM AVAILABLE TO RETAIL INVESTORS= IN THE EEA OR IN THE UNITED KINGDOM AND THEREFORE OFFERING OR SELLING THE = BONDS OR OTHERWISE MAKING THEM AVAILABLE TO ANY RETAIL INVESTOR IN THE EEA = OR IN THE UNITED KINGDOM MAY BE UNLAWFUL UNDER THE PRIIPS REGULATION. THE BONDS ARE NOT INTENDED TO BE OFFERED, SOLD OR OTHERWISE MADE AVAILABLE,= AND SHOULD NOT BE OFFERED, SOLD OR OTHERWISE MADE AVAILABLE, IN BELGIUM TO= =E2=80=9CCONSUMERS=E2=80=9D (CONSUMENTEN/CONSOMMATEURS) WITHIN THE MEANING= OF THE BELGIAN CODE OF ECONOMIC LAW (WETBOEK ECONOMISCH RECHT/CODE DE DROI= T ECONOMIQUE), AS AMENDED. ANY DECISION TO PURCHASE ANY OF THE BONDS SHOULD ONLY BE MADE ON THE BASIS = OF THE BASE PROSPECTUS OF UCB DATED 17 OCTOBER 2023, AS SUPPLEMENTED BY A S= UPPLEMENT N=C2=B01 DATED 24 OCTOBER 2023 AND A SUPPLEMENT N=C2=B02 DATED 5 = MARCH 2024 (TOGETHER, THE =E2=80=9CBASE PROSPECTUS=E2=80=9D) AND THE FINAL = TERMS RELATING TO THE BONDS. THE BASE PROSPECTUS AND THE FINAL TERMS ARE OR= WILL BE AVAILABLE ON UCB=E2=80=99S WEBSITE. EACH OF UCB, THE JOINT LEAD MA= NAGERS AND THEIR RESPECTIVE AFFILIATES EXPRESSLY DISCLAIMS ANY OBLIGATION O= R UNDERTAKING TO UPDATE, REVIEW OR REVISE ANY STATEMENT CONTAINED IN THIS C= OMMUNICATION WHETHER AS A RESULT OF NEW INFORMATION, FUTURE DEVELOPMENTS OR= OTHERWISE. THIS COMMUNICATION IS AN ADVERTISEMENT AND NOT A PROSPECTUS FOR THE PURPOSE= OF REGULATION 2017/1129, AS AMENDED. =C2=A0 GenericFile UCB PR Bond March 13 2024 NL (https://u7061146.ct.sendgrid.net/ls/click?upn= =3Du001.gqh-2BaxUzlo7XKIuSly0rCyBv9bezcPT-2BuItTLKIHepYLgZPrjEAa9NSU0c18dFG= dB1WANn2jADUMz4NpK-2BiFX8i4vKnhT1VLfvV8UKmZ-2Bww-3Ds_JX_2dCLUNbuBjhX746-2Fv= M63L9Hyn3KnTFGM-2BPPGCjZgmJl-2FKl1Z2nt-2BIfez2IJ0TSaz3mplcEW6ZopJ4gUd4Ia3MT= dQeFO93DwfIxs8cV3s33SbkEZvEGLNn-2B6FohpNoV33GtN0NR9PvLYqDMQ144S-2FWKO8XVzhe= 0Rd-2BArGzkTxzzu-2BHDSphZDHOOnACj3TmpW-2FLow8mhHrczBp3vNkbNEuHPBpdldY8anW6l= MvWKZjVUv0NFw3quIROuEMXkPknCOC0KOYpuVyVDKpOhHSguaC89Aa9Fs6CucTnvb-2B9wF6FzS= -2FhEk9Hf1KKzxR9ABrR-2FJUabRkJD3rJDfYQ2hNPH8l0xWHYEAjSGNlbeOUEIvSkww-3D Gen= ericFile UCB PR Bond March 13 2024 FR (https://u7061146.ct.sendgrid.net/ls/click?upn= =3Du001.gqh-2BaxUzlo7XKIuSly0rCyBv9bezcPT-2BuItTLKIHepYLgZPrjEAa9NSU0c18dFG= dFtgBZSrlPcKUrJLuCSPk5I6cdW0Y3AAfwUf1QxKTUNA-3DM4f2_2dCLUNbuBjhX746-2FvM63L= 9Hyn3KnTFGM-2BPPGCjZgmJl-2FKl1Z2nt-2BIfez2IJ0TSaz3mplcEW6ZopJ4gUd4Ia3MTdQeF= O93DwfIxs8cV3s33SbkEZvEGLNn-2B6FohpNoV33GtN0NR9PvLYqDMQ144S-2FWKO8XVzhe0Rd-= 2BArGzkTxzzu-2BHDSphZDHOOnACj3TmpW-2FLow8mhHrczBp3vNkbNEuHH-2FsaStxUnYrKG3B= KMDzovelins2xTHMdvJgmBKRBi2Y809G0287dfkgdacxXGvuXgSWj4bXGg0inlSO1c4IcDjEGT8= 2Swo85kdQlOq4HJqBd1UcNVjFaupmQfhtK9kiI-2B1CbTcv1QLDrnpoO1-2B0Mqw-3D Generic= File UCB PR Bond March 13 2024 ENG (https://u7061146.ct.sendgrid.net/ls/click?up= n=3Du001.gqh-2BaxUzlo7XKIuSly0rCyBv9bezcPT-2BuItTLKIHepYLgZPrjEAa9NSU0c18dF= Gd1WhUMUw-2BdEpEaYY6Ok3BXRqC5T8KUvFgcQ8hDdMcn-2BY-3D_TDM_2dCLUNbuBjhX746-2F= vM63L9Hyn3KnTFGM-2BPPGCjZgmJl-2FKl1Z2nt-2BIfez2IJ0TSaz3mplcEW6ZopJ4gUd4Ia3M= TdQeFO93DwfIxs8cV3s33SbkEZvEGLNn-2B6FohpNoV33GtN0NR9PvLYqDMQ144S-2FWKO8XVzh= e0Rd-2BArGzkTxzzu-2BHDSphZDHOOnACj3TmpW-2FLow8mhHrczBp3vNkbNEuHDTiT7KA0j8HX= jCX2TWJjbIiW2twmj5DwW9SYASx7cV5gzfgNBb2niO8zdOW8HSQTaKutcC0DMYa-2BPrrwjH6E3= S7BHU1fjvqoTbowocFtL1njaPLQATWSXZ-2BiymfZBJjoQolFYLcpV914bAqaV03X5Y-3D ______________________ If you would rather not receive future communications from UCB SA, please g= o to https://u7061146.ct.sendgrid.net/ls/click?upn=3Du001.gqh-2BaxUzlo7XKIu= Sly0rC3nfmD42E6tJ6HwHGmqtXbhtXDlQ2cTEdRpWV-2BrYPIUNYU74wwDag7GszGMeLNrOFbtf= xpuyBJEV3t1vlH5RBMAP8E7EeC61cjWUdI3oI2Dh1uNPojoJ83OWeSz6lIGJwyuKCaAqvDld3eR= J-2B4Ojr-2F0-3DxQ6n_2dCLUNbuBjhX746-2FvM63L9Hyn3KnTFGM-2BPPGCjZgmJl-2FKl1Z2= nt-2BIfez2IJ0TSaz3mplcEW6ZopJ4gUd4Ia3MTdQeFO93DwfIxs8cV3s33SbkEZvEGLNn-2B6F= ohpNoV33GtN0NR9PvLYqDMQ144S-2FWKO8XVzhe0Rd-2BArGzkTxzzu-2BHDSphZDHOOnACj3Tm= pW-2FLow8mhHrczBp3vNkbNEuHKoQFOQSR3Cwz-2FEM7ZIUumOpJJTl8G6PaacZCO-2FeTZ8-2F= WJ-2FoQhE-2FdRiKfkYC6OKpK1zzZaXP8iteC2YfGWbkhvlsjETKic5BoTeGNFfAy7UTWi1YvGK= -2Fls7dXzLmGtR5Sne-2FHVZUPtO6WsdO20XW2ok-3D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium

UCB's latest news

25/04/2024 18:00

UCB (EBR:UCB) UCB Media Room: UCB successfully completes institutional Eurobond issue

Transparency directive : regulatory news

UCB's latest news

Other stories